Journal Mobile Options
Table of Contents
Vol. 20, No. 5, 2014
Issue release date: Published online first (Issue-in-Progress)
Eur Addict Res 2014;20:248-253
(DOI:10.1159/000357941)

Can Intermittent Theta Burst Stimulation as Add-On to Psychotherapy Improve Nicotine Abstinence Results from a Pilot Study

Dieler A.C. · Dresler T. · Joachim K. · Deckert J. · Herrmann M.J. · Fallgatter A.J.
aDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, Ludwig Maximilians University Munich, Munich, bDepartment of Psychiatry, Psychosomatics and Psychotherapy, Julius Maximilian University Würzburg, Würzburg, cDepartment of Psychiatry and Psychotherapy, dLEAD Graduate School, and eCIN, Center of Integrative Neuroscience, Excellence Cluster, University of Tübingen, Tübingen, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Smoking is among the leading causes of mortality worldwide. Discontinuing smoking can increase life expectancy to the presmoking level. Unaided attempts are often ineffective, strengthening the necessity of cognitive-behavioral therapy (CBT), nicotine replacement or pharmacotherapy. Still, relapse rates are high. Recently, a modulation of nicotine craving, which predicts relapse, through transcranial magnetic stimulation to the prefrontal cortex was shown. In a pilot study, we investigated whether 4 sessions of intermittent theta burst stimulation (iTBS) as add-on treatment to CBT reduces nicotine craving and improves long-term abstinence (at 3, 6 and 12 months). Smokers were randomly assigned to a treatment (n = 38) or a sham group (n = 36). Although we did not find reduced craving, we could show higher abstinence rates in the treatment group at 3 months. At 6 and 12 months abstinence rates did not differ significantly. Results at 12 months, however, have to be interpreted cautiously due to significant differences in the dropout rates between the two groups at this time point. We provide first evidence for a beneficial effect of additional iTBS on intermediate nicotine abstinence; however, the low number of iTBS sessions might have prevented longer effects. More lasting effects might be achieved by iTBS maintenance sessions in analogy to the treatment of depression. © 2014 S. Karger AG, Basel



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S: Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006;368:647-658.
  2. Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004;328:1519.
  3. Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-1210.
  4. Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff: A clinical practice guideline for treating tobacco use and dependence: 2008 update: a U.S. Public Health Service report. Am J Prev Med 2008;35:158-176.
  5. WHO: http://www.euro.who.int/en/what-we-publish/information-for-the-media/sections/latest-press-releases/world-no-tobacco-day-may-31,-2010-women-are-huge-potential-market-for-the-tobacco-industry (accessed August 19, 2010).
  6. Doll R, Hill AB: Mortality in relation to smoking: ten years' observations of British doctors. BMJ 1964;1:1460-1467.
  7. Chenot JF, Keller S: Nikotinstopp - was hilft dabei? Z Allgemeinmed 2004;80:113-118.
  8. Mallin R: Smoking cessation: integration of behavioral and drug therapies. Am Fam Physician 2002;65:1107-1114.

    External Resources

  9. Lancaster T, Stead L, Silagy C, Sowden A: Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000;321:355-358.
  10. Pogarell O, Koch W, Pöpperl G, Tatsch K, Jakob F, Zwanzger P, Mulert C, Rupprecht R, Möller H-J, Hegerl U, Padberg F: Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: Preliminary results of a dynamic [123I] IBZM SPECT study. J Psychiatr Res 2006;40:307-314.
  11. Grace AA: The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 2000;95(suppl 2):S119-S128.
  12. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C: Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nature Neurosci 2005;8:147-148.
  13. Spyraki C, Fibiger HC, Phillips AG: Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology 1983;79:278-283.
  14. Förstl H, Hautzinger M, Roth G: Neurobiologie psychischer Störungen. Berlin, Springer, 2006.
  15. Goldstein RZ, Volkow ND: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002;159:1642-1652.
  16. Koob GF, Le Moal M: Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001;24:97-129.
  17. Koob GF, Le Moal M: Plasticity of reward neurocircuitry and the ‘dark side' of drug addiction. Nat Neurosci 2005;8:1442-1444.
  18. Gordiev M, Engstrom PF, Khasanov R, Moroshek A, Sitdikov R, Dgavoronkov V, Schnoll RA: Genetic analysis of polymorphisms in dopamine receptor and transporter genes for association with smoking among cancer patients. Eur Addict Res 2013;19:105-111.
  19. Mutschler J, Abbruzzese E, von der Goltz C, Dinter C, Mobascher A, Thiele H, Diaz-Lacava A, Dahmen N, Gallinat J, Majic T, Petrovsky N, Kornhuber J, Thuerauf N, Grunder G, Brinkmeyer J, Wienker T, Wagner M, Winterer G, Kiefer F: Genetic variation in the neuropeptide Y gene promoter is associated with increased risk of tobacco smoking. Eur Addict Res 2012;18:246-252.
  20. Camprodon JA, Martínez-Raga J, Alonso-Alonso M, Shih MC, Pascual-Leone A: One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug Alcohol Depend 2007;86:91-94.
  21. Mishra BR, Nizamie SH, Das B, Praharaj SK: Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study. Addiction 2010;105:49-55.
  22. Amiaz R, Levy D, Vainiger D, Grunhaus L, Zangen A: Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction 2009;104:653-660.
  23. Eichhammer P, Johann M, Kharraz A, Binder H, Pittrow D, Wodarz N, Hajak G: High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking. J Clin Psychiatry 2003;64:951-953.

    External Resources

  24. Boggio PS, Sultani N, Fecteau S, Merabet L, Mecca T, Pascual-Leone A, Basaglia A, Fregni F: Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: a double-blind, sham-controlled study. Drug Alcohol Depend 2008;92:55-60.
  25. Fregni F, Liguori P, Fecteau S, Nitsche MA, Pascual-Leone A, Boggio PS: Cortical stimulation of the prefrontal cortex with transcranial direct current stimulation reduces cue-provoked smoking craving: a randomized, sham-controlled study. J Clin Psychiatry 2008;69:32-40.
  26. Barr MS, Fitzgerald PB, Farzan F, George TP, Daskalakis ZJ: Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders. Curr Drug Abuse Rev 2008;1:328-339.
  27. Jansen JM, Daams JG, Koeter MW, Veltman DJ, van den Brink W, Goudriaan AE: Effects of non-invasive neurostimulation on craving: a meta-analysis. Neurosci Biobehav Rev 2013;37:2472-2480.
  28. Oberman L, Edwards D, Eldaief M, Pascual-Leone A: Safety of theta burst transcranial magnetic stimulation: a systematic review of the literature. J Clin Neurophysiol 2011;28:67-74.
  29. Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC: Theta burst stimulation of the human motor cortex. Neuron 2005;45:201-206.
  30. Schumann A, Rumpf HJ, Meyer C, Hapke U, John U: Deutsche Version des Fagerström-Test for Nicotine Dependence (FTND-G) und des Heaviness of Smoking Index (HSI-G); in Glöckner-Rist A, Rist F, Küfner H (eds): Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Mannheim, Zentrum für Umfragen, Methoden und Analysen, 2003.
  31. WHO: International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). (accessed August 20, 2010).
  32. Wittchen HU, Zaudig M, Fydrich T: SKID. Strukturiertes Klinisches Interview für DSM-IV. Göttingen, Hogrefe, 1997.
  33. Wassermann EM: Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol1998;108:1-16.
  34. Raw M, McNeill A, West R: Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority. Thorax 1998;53(suppl 5): S1-S19.
  35. Mucha RF, Pauli P: Die deutsche Version des Questionnaire on Smoking Urges (QSU-G); in Glöckner-Rist A, Rist F, Küfner H (eds): Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Mannheim, Zentrum für Umfragen, Methoden und Analysen, 2003.
  36. Schumann A, Rumpf HJ, Meyer C, Hapke U, John U: Deutsche Version des Fragebogens zur Self-Efficacy für Raucher (SER-G); in Glöckner-Rist A, Rist F, Küfner H (eds): Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES), Version 3.00. Mannheim, Zentrum für Umfragen, Methoden und Analysen, 2003.
  37. Jasper HH: The ten-twenty electrode system of the International Federation. Electroencephalogr Clin Neurophysiol 1958;10:371-375.
  38. Klem GH, Lüders HO, Jasper HH, Elger C: The ten-twenty electrode system of the International Federation. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 1999;52:3-6.

    External Resources

  39. Herwig U, Satrapi P, Schönfeldt-Lecuona C: Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr 2003;16:95-99.
  40. Loo CK, Taylor JL, Gandevia SC, McDarmont BN, Mitchell PB, Sachdev PS: Transcranial magnetic stimulation (TMS) in controlled treatment studies: are some ‘sham' forms active? Biol Psychiatry 2000;47:325-331.
  41. Li X, Nahas Z, Anderson B, Kozel FA, George MS: Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety 2004;20:98-100.
  42. O'Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC: Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 2005;66:1524-1528.
  43. Herwig U, Cardenas-Morales L, Connemann BJ, Kammer T, Schönfeldt-Lecuona C: Sham or real - post hoc estimation of stimulation condition in a randomized transcranial magnetic stimulation trial. Neurosci Lett 2010;471:30-33.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50